Prescription

MRD / Regn No.

: 20190000053

Date

: 24/06/2026

Patient Name

: Badar unissa Moheadeen

Age & Gender

: 42 Yrs. / Female

Contact No.

: 9445953441

UHID

:

Ht / Wt / BMI

: 160 / 137 / 53.52

BP S / BP D

: 140 / 70

Allergies

: NKA

Referred By

:

Problem List	:	TYPE 2 DM (17/Jan/2001) \| HYPERTENSION (22/Jul/2021) \| OBESITY CLASS 3 (22/Jul/2000) \|
Subjective	:	INCORRECT TECHNIQUE
Objective	:	NONE
Analysis	:	OBESITY,HYPERTENSION,TYPE 2 DM IMPROVING
Plan	:	INCREASE TIRZEPATIDE TO 12.5 MG,INCREASE INSULIN TO 22-0-0SEE ME IN 1 MONTH WITH FBS 2HPP
Salient Investigations	:	GLYCOSYLATED HEMOGLOBIN (HBA1C): 9.5 % \| HEMOGLOBIN: 13.5 g/dL \| MCH: 26.5 pg \| MCHC: 31.2 gm % \| MCV: 85.1 fl \| PLATELETS: 359 thou cells/ ul \| RBC COUNT: 5.09 million/ul \| TOTAL COUNT WBC: 9750 Cells/cmm \| A\G RATIO: 1.06 g/dl \| ALBUMIN (SERUM): 3.70 g/dL \| ALKALINE PHOSPHOTASE: 90.2 IU/L \| DIRECT BILIRUBIN: 0.09 mg/dl \| GAMMA GLUTAMYL TRANSFERASE (GGT): 22 U/L \| GLOBULIN: 3.50 g/dl \| INDIRECT BILIRUBIN: 0.33 \| SGOT (AST): 16.6 U/L \| SGPT (ALT): 22.9 IU/L \| TOTAL BILIRUBIN: 0.42 mg/dL \| TOTAL PROTEIN: 7.2 g/dl \| TOTAL T3: 0.67 \| TOTAL T4: 10.95 mcg/dL \| TSH : 6.463 mIU/L \| HDL HIGH DENSITY LIPOPROTEIN: 60.4 mg/dL \| LDL LOW DENSITY LIPOPROTEIN: 128 mg/dL \| TGL TRIGLYCERIDE: 314 mg/dL \| TOTAL CHO/HDL RATIO: 4.17 \| TOTAL CHOLESTEROL: 251.8 mg/dl \| VLDL: 62.82 mg/dl \| HDL HIGH DENSITY LIPOPROTEIN: 60.4 mg/dL \| LDL LOW DENSITY LIPOPROTEIN: 128 mg/dL \| TGL TRIGLYCERIDE: 314 mg/dL \| TOTAL CHO/HDL RATIO: 4.17 \| TOTAL CHOLESTEROL: 251.8 mg/dl \| VLDL: 62.82 mg/dl \| IRON: 52.5 mcg/dL \| TIBC: 359.80 mcg/dL \| CALCIUM: 8.9 mg/DL \| FASTING PLASMA GLUCOSE (FPG): 105.6 mg/dL \| FIB4: 0.41 \| FIB4: 0.41 \| FIB4: 0.41 \| FIB4: 0.41 \| FIB4: 0.41 \| FIB4: 0.41 \| CHLORIDE: 107 meq/L \| POTASSIUM: 5.1 meQ/L \| SODIUM: 136.9 meq/L \| UREA: 32 mg/dL \| BUN BLOOD UREA NITROGEN: 14.95 mg/dL \| CREATININE: 0.63 mg/dL \| EGFR EGLOMERULAR FILTRATION RATE: 110.83 mL/min/1.73m2

S#	Generic (Trade) Name	Route	Dosage	Usage	Duration
1	GLARGINE (INJ U300) TOUJEO Medicine For GLUCOSE CONTROL	SQ	90-0-0 UNITS	AFTER FOOD	TILL NEXT VISIT
	MAY CAUSE HYPOGLYCEMIA

2	DAPAGLIFLOZIN 10 MG UDAPA Medicine For DIABETES OBESITY HEART AND KIDNEY PROTECTION	PO	1-0-0	BEFORE FOOD	TILL NEXT VISIT
	MAY CAUSE GENITOURINARY INFECTION. INFORM IF THERE IS DYSURIA OR GENITAL ITCHING

3	TELMISARTAN CTD 40 MG ERITEL CH 40 MG Medicine For HYPERTENSION KIDNEY PROTECTION	PO	0-0-1	AT BEDTIME	TILL NEXT VISIT

4	CAPSULE DILTIAZEM ER 120 MG ANGIZEM CD 120 MG ER Medicine For HYPERTENSION	PO	0-0-1	BEFORE FOOD	TILL NEXT VISIT
	MAY CAUSE HEADACHE CONSTIPATION DIZZINESS FLUSHING

5	INJECTION LISPRO (INJ U100) HUMALOG Medicine For T1DM T2DM	SQ	12-16-12 UNITS	BEFORE FOOD	TILL NEXT VISIT
	MAY CAUSE HYPOGLYCEMIA

6	INJECTION TIRZEPATIDE 12.5 MG MOUNJARO Medicine For OBESITY DIABETES	SQ	ONCE A WEEK	AS DIRECTED NO RELATION TO FOOD	TILL NEXT VISIT
	MAY CAUSE NAUSEA VOMITING DIARRHEA OR AVERSION TO CERTAIN FOODS

Refill : 0 / Substitution:

Education

:

Next Visit

: 23/Aug/2026

Tests Suggested For Next Visit

: FBS 2HPP HBA1C